Covering cancer research for @NIH. Always making time for fun and healthy eats! Views are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Linda Wang
Scientists engineer ready-to-use cancer-fighting T cells for solid tumors
T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down cancer with precision. It's similar to another treatment, CAR T-cell therapy, but with one key difference: CAR T-cell therapy can only spot proteins that naturally appear outside a cancer cell. TCR therapy, however, can also catch small protein fragments from inside the cell that are carried to the surface and displayed like little name tags.
Scientists engineer ready-to-use cancer-fighting T cells for solid tumors
Engineered T cells, designed to recognize and attack tumor cells, illustrating a new approach to developing off-the-shelf cell therapies for solid tumors. Credit: Lili Yang Lab/UCLA T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down cancer with precision. It's similar to another treatment, CAR T-cell therapy, but with one key difference: CAR T-cell therapy can only spot proteins that naturally appear outside a cancer cell.
UCLA scientists engineer ready-to-use cancer-fighting T cells for solid tumors
Key takeaways UCLA researchers have developed a way to mass-produce cancer-fighting T cells from blood stem cells found in cord blood, engineered to target a protein found in many solid tumors — creating uniform batches instead of custom treatments for each patient.
Trapped and Traced No More - SB 690 Will Stem Tidal Wave of California Invasion of Privacy Claims
The flood of California Invasion of Privacy Act (CIPA) lawsuits targeting cookies, pixels and other tracking tools under antiquated laws that did not contemplate the internet is on its way to an end. For years, plaintiffs’ lawyers and individuals have used CIPA to send demand letters, commence arbitrations and class action lawsuits against companies of every size alleging that website tracking was illegal eavesdropping.
Trapped and Traced No More - SB 690 Will Stem Tidal Wave of California Invasion of Privacy Claims
The flood of California Invasion of Privacy Act (CIPA) lawsuits targeting cookies, pixels and other tracking tools under antiquated laws that did not contemplate the internet is on its way to an end. For years, plaintiffs’ lawyers and individuals have used CIPA to send demand letters, commence arbitrations and class action lawsuits against companies of every size alleging that website tracking was illegal eavesdropping.
AI Hiring Litigation: Key Lessons for Employers | JD Supra
As businesses implant AI tools deeper into hiring, the litigation keeps coming - and the courts are expected to fill in the gaps left by the absence of settled precedent. The latest guidance arrives from the Northern District of California, where a magistrate judge has issued a discovery ruling in the closely watched Mobley v. Workday, Inc. litigation that tells employers a great deal about how these cases will be fought.
AI Hiring Litigation: Key Lessons for Employers
As businesses implant AI tools deeper into hiring, the litigation keeps coming – and the courts are expected to fill in the gaps left by the absence of settled precedent. The latest guidance arrives from the Northern District of California, where a magistrate judge has issued a discovery ruling in the closely watched Mobley v. Workday, Inc. litigation that tells employers a great deal about how these cases will be fought.
For Young Adults, Limiting Social Media Use Doesn’t Improve Well-Being
What happens when young adults are asked to slash their social media use to 30 minutes a day? In a new set of studies, most did not follow through, and those who did cut back reported no greater improvement in well-being than their peers who used social media as usual.
Inflated Confidence May Not Give Children a Learning Advantage After All
Young children often overestimate what they can do. That overconfidence may help them approach challenges without fear, but it can also get them into trouble. Children who overestimate their physical abilities, for example, may take risks that make accidental injuries more likely. Previous research has suggested that overconfidence may also help children learn.
UCLA scientists build ‘cell villages’ to map the genetics of brain cell fitness
Key takeaways UCLA researchers grew brain cells from dozens of genetically distinct donors together in a cell village, then built a statistical tool called Townlet to measure each donor’s cell fitness — how well their cells grow and survive.
Seeking Empathy in the Age of AI
Defining empathy • The AI advantage • Wisdom of the crowd • The AI penalty • The risks of frictionless support • Supporting human relationships Quick Take AI can generate responses that people experience as empathic, even though it cannot feel another person’s pain. The rise of AI is forcing psychologists to clarify what empathy means: understanding, emotional sharing, compassion, validation, or simply helping someone feel heard.
UCLA scientists bring real-world experiences — and pop culture — into LA classrooms
For many high school students, the term “scientist” conjures someone who doesn’t look like them or share their background. The UCLA Broad Stem Cell Research Center High School Outreach Program sets out to change that, bringing young researchers directly into classrooms for hands-on, interactive presentations.
Our brains may be automatically filtering out negative words
Credit: Image generated by the editorial team using AI for illustrative purposes. We tend to assume that emotionally charged words are more likely to grab our attention. An insult shouted across a crowded room or a disturbing phrase overheard on television can seem impossible to ignore. But a new study published in Psychological Science suggests the opposite may happen before words reach conscious awareness.
Our Brains May Be Automatically Filtering Out Negative Words
We tend to assume that emotionally charged words are more likely to grab our attention. An insult shouted across a crowded room or a disturbing phrase overheard on television can seem impossible to ignore. But a new study published in Psychological Science suggests the opposite may happen before words reach conscious awareness.
From the lab to the runway to a Fulbright: UCLA senior is just getting started
In any given week, Amadu Tadesse might be pipetting samples in a Westwood stem cell research lab, walking the runway in a fashion show, or scoring goals on the intramural soccer field. This June, though, he’ll say goodbye to his time at UCLA as he graduates with a double major in microbiology, immunology & molecular genetics and African American Studies.
AI in the Workplace: Managing Bias, Privacy and Legal Risk
Artificial Intelligence (AI) is being adopted at a rapid pace across industries – and for good reasons. AI-driven tools increase efficiency, reduce administrative burdens, and enhance data-driven decision-making. In the employment context, businesses commonly use AI for applicant screening, hiring and promotion decisions, productivity monitoring, and other personnel actions. AI integration has significantly increased during the hiring process.
Assessment of Genetic Correlations Between Tobacco or Alcohol Use and Neurodegenerative Diseases Using East Asian Genetic Ancestry Genome-Wide Association Study Results
1 Introduction Alzheimer's Disease (AD) and Parkinson's Disease (PD) are the two most prevalent neurodegenerative diseases globally, with over 56 million and 11 million individuals estimated to be affected by AD or by PD, respectively as of 2021 (GBD 2021 Diseases and Injuries Collaborators 2024). The risk of these conditions increases with age, and the number of affected individuals is only expected to increase.
A child's environment may shape how their brain solves problems
Credit: Unsplash/CC0 Public Domain For decades, researchers have documented an achievement gap between children from higher- and lower-income families. On average, children with more resources perform better in school and on cognitive tests. A new study looks at the cognitive and brain processes underlying the achievement gap.
A child's environment may shape how their brain solves problems
6 hours ago In a startling development, archaeologists say these mysterious skeletons are the father and son of this legendary ruler. Here’s what you’ll learn when you read this story: Alexander the Great was one of history’s greatest generals, but his father—Philip II—was no slouch either. His rule gave rise to …
Xin Liu Named to the 2026 TIME100 Philanthropy List
Updated: May 14 NEW YORK (May 14, 2026) — We're honored to share that TIME named Enlight Foundation President and Founder Xin Liu to the 2026 TIME100 Philanthropy list recognizing people who are shaping the future of giving. For Xin and the Enlight Foundation, this recognition isn’t about a single person—it’s about the growing movement of young leaders, social entrepreneurs, and changemakers we are privileged to support.
A Child’s Environment May Shape How Their Brain Solves Problems
For decades, researchers have documented an achievement gap between children from higher- and lower-income families. On average, children with more resources perform better in school and on cognitive tests. A new study looks at the cognitive and brain processes underlying the achievement gap.
Abinopharm Reports Clinical Success: Double-Blind Trial Validates AbinoNutra® NMN for Post-Exercise Muscle Recovery
AbinoNutra®NMN from Abinopharm, Inc. The second human clinical trial of AbinoNutra® NMN demonstrates that NMN aids post-exercise muscle recovery in young adults and holds significant potential for sports nutrition by reducing exercise-induced inflammation. New human clinical data demonstrates the safety and efficacy of AbinoNutra® NMN in reducing inflammation and balancing mitochondrial content in young athletes.
For young adults, recollection of alcohol addiction may differ from reality, study suggests
Credit: Unsplash/CC0 Public Domain When young adults are asked to recall their drinking habits, their recollections may not always match what actually happened in their day-to-day lives, a new study suggests. Though people tend to remember major events, like an accident or a fight, they may lose track of more subjective experiences, such as cravings or changes in alcohol tolerance.
For Young Adults, Recollection of Alcohol Addiction May Differ From Reality
When young adults are asked to recall their drinking habits, their recollections may not always match what actually happened in their day-to-day lives, a new study suggests. Though people tend to remember major events, like an accident or a fight, they may lose track of more subjective experiences, such as cravings or changes in alcohol tolerance.
AI Lawsuit Pushes the Boundaries of AI Litigation—and May Signal a New Wave
New FCRA Class Action Expands Potential Scope of AI Litigation In January 2026, job applicants Erin Kistler and Sruti Bhaumik filed a class action against Eightfold AI Inc., alleging that the company’s AI hiring platform operated as an unregistered consumer reporting agency under the Fair Credit Reporting Act (FCRA). Unlike most AI-related litigation, which tends to focus on algorithmic bias, this case targets the privacy implications of AI.
Are AI Chats Privileged? Courts Split on Attorney-Client and Work-Product Protection
AI Chat Privilege in Litigation: Warner v. Gilbarco and Heppner Point in Opposite Directions Shortly after the ruling in Warner v. Gilbarco – where a court suggested that ChatGPT chat history could be covered by the work-product doctrine – a federal district court in New York reached a very different conclusion. In United States v.
AI and the Work-Product Doctrine: A New Frontier
Can AI-Generated Legal Drafts Be Protected as Work Product? As the use of artificial intelligence (AI) continues to accelerate across industries, it is unsurprising that courts are beginning to confront its implications in the litigation context. A recent federal decision underscores just how quickly these issues are moving.
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades. The most aggressive subtypes are a significant driver of that trend: uterine papillary serous carcinoma accounts for just 10% of diagnoses but nearly 40% of deaths. Subscribe to our newsletter for the latest sci-tech news updates.
Microscopy image of uterine papillary serous carcinoma, an aggressive subtype of endometrial cancer. Credit: Neda Moatamed/Sanaz Memarzadeh Lab Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades. The most aggressive subtypes are a significant driver of that trend: uterine papillary serous carcinoma accounts for just 10% of diagnoses but nearly 40% of deaths.
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer
Key takeaways UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective at fighting endometrial cancer than current immunotherapies in experimental models. While personalized treatments can cost six figures and require weeks to manufacture, this therapy can be mass-produced and stored ready-to-use at about $5,000 per dose.
Connected Care For Canadians Act Aims To Promote Unobstructed Access To Electronic Health Information
Teresa A. Reguly’s articles from Torys LLP are most popular: in Canada with readers working within the Healthcare and Oil & Gas industries Torys LLP are most popular: within Insolvency/Bankruptcy/Re-Structuring topic(s) with Senior Company Executives, HR and Inhouse Counsel Originally introduced in the House of Commons on June 6, 2024, Bill S-5, the Connected Care for Canadians Act (the Act), was reintroduced by the Senate and received first reading on February 4, 2026.
Enterprise Risk Management im Geschäft mit China
China ist anders und will so bleiben. International agierende Unternehmen in China folgen zugleich derselben betriebswirtschaftlichen Logik wie überall auf der Welt. Viele Bücher zu den wirtschaftlichen Gegebenheiten in China sind an der volkswirtschaftlichen und politischen Entwicklung des Landes orientiert, dieses Buch nimmt die Perspektive von Entscheidern im Geschäft mit China ein. Über 50 Geschäftsrisiken international agierender Unternehmen in China werden beschrieben und analysiert.
An off-the-shelf immunotherapy for targeting solid tumors: Ready-to-use CAR-NKT cells show promise
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant natural killer T cells, or NKT cellspowerful immune cells with a unique ability to infiltrate solid tumorsand systematically compared four targeting systems, called chimeric antigen receptors, or CARs, that direct these cells to attack cancer.
An off-the-shelf immunotherapy for targeting solid tumors: Ready-to-use CAR-NKT cells show promise
L-R: Tyler Halladay, Yichen Zhu, Yuning Chen, Yanruide (Charlie) Li and Lili Yang. Credit: UCLA Broad Stem Cell Research Center A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors.
UCLA scientists identify optimal design for off-the-shelf immunotherapy targeting solid tumors
Findings A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant natural killer T cells, or NKT cells — powerful immune cells with a unique ability to infiltrate solid tumors — and systematically compared four targeting systems, called chimeric antigen receptors, or CARs, that direct these cells to attack cancer.
Court Provides New Road to Early Victory Defeating CIPA Complaint | JD Supra
A Los Angeles County trial court granted a Motion for Judgment on the Pleadings disposing of a CIPA (California Invasion of Privacy Act) complaint against a website operator before formal discovery or other expensive litigation occurred. Rodriguez v. Ink America International, LASC 25STCV153 (Dec. 10, 2025).
UCLA scientists develop one-product-fits-all immunotherapy for pancreatic cancer
“Developing a therapy that targets both the primary tumor and its metastases in preclinical studies — one that can be ready to use off-the-shelf — represents a fundamental shift in how we might treat this disease,” said senior author Dr. Lili Yang, a professor of microbiology, immunology and molecular genetics and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.
Scientists develop one-product-fits-all immunotherapy for pancreatic cancer
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout the body. The five-year survival rate for metastatic cases hovers around 2–3%, and median survival is often measured in months rather than years. Now, UCLA researchers have engineered a novel immunotherapy that could offer new hope for a disease that has remained stubbornly resistant to treatment advances for decades.
UCLA scientists develop one-product-fits-all immunotherapy for pancreatic cancer
Key takeaways: UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting tumors in several different mouse models of pancreatic cancer. Unlike current personalized cell therapies, which require weeks to manufacture, this novel therapy can be mass-produced and stored ready-to-use at a fraction of the cost.
Web Browsers Must Allow Users to Opt Out | JD Supra
New laws are in place for businesses that operate websites in California. Starting January 1, 2027, web browsers must include functionality that enables the browser to send an opt-out preference signal to website operators (an opt-out preference signal is defined as a signal that communicates the consumer’s choice to opt out of the sale and sharing of the consumer’s personal information). On October 8, 2025, Governor Gavin Newsom signed the California Opt Me Out Act (AB 566) into law.
CIPA Update: MSJ Win For Website Operators | JD Supra
The U.S. District Court for the Northern District of California gave website operators an expedited exit from privacy-related complaints and lawsuits under the California Invasion of Privacy Act (CIPA), a 1960s-era law designed to prevent unlawful telephone wiretapping. Plaintiffs attempt to use outdated CIPA framework to attack the use of cookies and pixels (and other tracking mechanisms) that is standard practice for websites.
UCLA scientists develop one-product-fits-all immunotherapy for breast cancer
UCLA researchers have developed a novel therapy that could fundamentally change the treatment plan for this deadly disease. In a study published in the Journal of Hematology & Oncology, the team details how this new type of immunotherapy, called CAR-NKT cell therapy, could attack tumors from multiple fronts while dismantling their protective shields.
Scientists develop one-product-fits-all immunotherapy for breast cancer
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful therapies. UCLA researchers have developed a novel therapy that could fundamentally change the treatment plan for this deadly disease.
UCLA scientists develop one-product-fits-all immunotherapy for breast cancer
Key takeaways UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting cancer in tumor samples from late-stage triple-negative breast cancer patients. While personalized treatments can cost six figures and require weeks to manufacture, this therapy can be mass-produced from donated blood stem cells and stored ready-to-use at about $5,000 per dose.
Illinois Head Start Joins Museums for Child Learning Expansion - Edwardsville Children's Museum Participates
SPRINGFIELD, Ill. — The Illinois Head Start Association (IHSA) announced a new statewide partnership with Children’s Museums across Illinois to expand educational opportunities for Head Start and Early Head Start children and their families during October, which is Head Start Awareness Month.
One-time gene therapy could end lifelong transfusions for rare blood disease
Thanks to in-utero blood transfusion technology, what was once a fatal diagnosis in the womb can now result in live births. However, this medical advancement created a new challenge: a growing population of children born with that diagnosis—the severe, inherited blood disorder alpha thalassemia—which requires lifelong specialized care.
UCLA scientists advance stem cell gene therapy for deadly blood disorder, alpha thalassemia major
Key takeaways UCLA researchers have made strides in developing a stem cell gene therapy for alpha thalassemia major, a severe, inherited blood disorder in which patients lack the gene needed to produce hemoglobin. The therapy involves collecting a patient’s own blood stem cells, adding the missing alpha-globin gene using a viral vector, and then returning the corrected cells to the patient.
ACS establishes Committee on the Advancement of LGBTQ+ Chemists
On Aug. 20, during the American Chemical Society Fall 2025 meeting in Washington, DC, the ACS Council approved a motion to establish the Committee on the Advancement of LGBTQ+ Chemists (CALC). "Especially in recent times, many LGBTQ+ chemists have felt isolated and excluded from important conversations," said Sam Brunclik, who will chair the new committee, in a recent post on Instagram from the ACS Pride account.
Antibiotic Resistant Superbugs Always a Risk for Cancer Patients
GettyImages/nito100 As if battling cancer weren’t challenging enough, an invisible threat is making cancer care even more complicated: antimicrobial-resistant superbugs that are increasingly hard to treat.
UCLA scientists map primate ovarian reserve development, offering key insights into women’s health
Key takeaways UCLA researchers have created a first-of-its-kind blueprint that captures how the ovarian reserve — a female’s lifetime supply of eggs — forms in primates. The work provides the first cellular explanation for mini-puberty, a discovery that could serve as an early biomarker for identifying those at risk of ovarian dysfunction.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Linda
Contact Linda, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack